Success Metrics

Completion Rate
0%(0/2)
Active Trials
1(33%)
Terminated
2(67%)

Phase Distribution

Ph phase_2
2
67%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(2)

Detailed Status

Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

recruiting133%
terminated267%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

SAINT in Postpartum Depression (PPD)

NCT07210255
terminatedphase_2

The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition

NCT03693105
terminatedphase_2

SAINT for MDD in an Inpatient Setting Follow-on

NCT06462820

Clinical Trials (3)

Showing 3 of 3 trials
NCT07210255Not Applicable

SAINT in Postpartum Depression (PPD)

Recruiting
NCT03693105Phase 2

The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition

Terminated
NCT06462820Phase 2

SAINT for MDD in an Inpatient Setting Follow-on

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3